Opus Genetics is trading at $4.15, up +5.60%, as biotech and major U.S. indexes are higher.
- No verified company-specific catalyst was reported for November 4.
- The November 3 announcement concerned a November 10 conference appearance, not a major business or regulatory development.
- No volume figures were provided, so trading activity cannot be assessed.